This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Megraud F (2004) Basis for the management of drug-resistant Helicobacter pylori infection. Drugs 64: 1893–1904
Labenz J et al. (1991) Ciprofloxacin–omeprazole combination therapy for eradication of Helicobacter pylori. Z Gastroenterol 29: 143–145
Nista EC et al. (2003) Levofloxacin-based triple therapy vs quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial. Aliment Pharmacol Ther 18: 627–633
di Caro S (2002) Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication. Aliment Pharmacol Ther 16: 527–532
Toracchio S and Marzio L (2003) Primary and secondary antibiotic resistance of Helicobacter pylori strains isolated in central Italy during the years 1998–2002. Dig Liver Dis 35: 541–545
Acknowledgements
The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Kist, M. How effective is moxifloxacin for the first-line treatment of patients with Helicobacter pylori infection?. Nat Rev Gastroenterol Hepatol 2, 450–451 (2005). https://doi.org/10.1038/ncpgasthep0288
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpgasthep0288